NCT06317948

Brief Summary

Investigators central hypothesis is that it is possible to create libraries of "consistent" Knowledge-Based plan-models derived from large Institutional experiences. These libraries can be used to guide automated RT planning and serve as tools to assist centers for plan quality assurance (QA) and plan prediction. Quantifying Inter-institute variability of RT planning and building libraries of interchangeable and validated multi-Institutional KB plan prediction models is expected to impact on the quality of planning at the national level. The project has the potential of facilitating the introduction of AI approaches in plan optimization, thus reducing intra and inter-Institute planning variability. Improving plan quality is expected to translate into better outcome after RT in terms of local control and, even more, of side effects and Quality of life. Positive impact is also expected in patient selection for advanced techniques, in plan audit and plan optimization in clinical trials, in technology comparison and cost-benefit analyses as well as in the RT educational field.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 28, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2025

Completed
Last Updated

March 20, 2024

Status Verified

March 1, 2024

Enrollment Period

Same day

First QC Date

March 12, 2024

Last Update Submit

March 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • model interchangeability

    interchangeability will be assessed by considering: a) the fraction of patients identified as "anatomy outlier" (in terms of out of the geometric features (GF) boundary of each single model) once the model coming from Institute X is applied to patients of Institute Y (modX-Y) and vice-versa (modY-X); b) the relative differences in DVH predictions between modX-Y and modY-X, including and not including the previously recognized "GF outlier" patients. Based on these results and on their clinical interpretation, sub-groups of KB-models with "high" interchangeability will be tentatively identified and the relationships between GF and interchangeability quantified.

    3 years

Interventions

In order to assess inter-Institute variability of DVH prediction of the various models, for the different situations and the different OARs, DVH and dose statistics (min, mean, median, max and SD of the dose received by each OAR) predicted on the patients owning to the different centers by the different models will be compared

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

prostate cancer, breast cancer and for selected SBRT situations (spine and prostate, according to RTOG 0631 and 0938 schemes respectively).

You may qualify if:

  • real life consecutive (or randomly chosen) plan data of patients treated for prostate cancer during the last 10 years;
  • real life consecutive (or randomly chosen) plan data of patients treated for breast cancer during the last 10 years;
  • real life consecutive (or randomly chosen) plan data of patients treated for selected SBRT situations (spine and prostate, according to RTOG 0631 and 0938 schemes respectively) during the last 10 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Ospedale San Raffaele

Milan, 20133, Italy

Location

Related Publications (5)

  • Esposito PG, Castriconi R, Mangili P, Broggi S, Fodor A, Pasetti M, Tudda A, Di Muzio NG, Del Vecchio A, Fiorino C. Knowledge-based automatic plan optimization for left-sided whole breast tomotherapy. Phys Imaging Radiat Oncol. 2022 Jun 23;23:54-59. doi: 10.1016/j.phro.2022.06.009. eCollection 2022 Jul.

    PMID: 35814259BACKGROUND
  • Tudda A, Castriconi R, Benecchi G, Cagni E, Cicchetti A, Dusi F, Esposito PG, Guernieri M, Ianiro A, Landoni V, Mazzilli A, Moretti E, Oliviero C, Placidi L, Rambaldi Guidasci G, Rancati T, Scaggion A, Trojani V, Fiorino C. Knowledge-based multi-institution plan prediction of whole breast irradiation with tangential fields. Radiother Oncol. 2022 Oct;175:10-16. doi: 10.1016/j.radonc.2022.07.012. Epub 2022 Jul 19.

    PMID: 35868603BACKGROUND
  • Monticelli D, Castriconi R, Tudda A, Fodor A, Deantoni C, Gisella Di Muzio N, Mangili P, Del Vecchio A, Fiorino C, Broggi S. Knowledge-based plan optimization for prostate SBRT delivered with CyberKnife according to RTOG0938 protocol. Phys Med. 2023 Jun;110:102606. doi: 10.1016/j.ejmp.2023.102606. Epub 2023 May 15.

    PMID: 37196603BACKGROUND
  • Castriconi R, Esposito PG, Tudda A, Mangili P, Broggi S, Fodor A, Deantoni CL, Longobardi B, Pasetti M, Perna L, Del Vecchio A, Di Muzio NG, Fiorino C. Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy. Front Oncol. 2021 Aug 24;11:712423. doi: 10.3389/fonc.2021.712423. eCollection 2021.

    PMID: 34504790BACKGROUND
  • Placidi L, Griffin P, Castriconi R, Tudda A, Benecchi G, Burns M, Cagni E, Markham C, Landoni V, Moretti E, Oliviero C, Guidasci GR, Meffe G, Rancati T, Scaggion A, McGoldrick K, Panettieri V, Fiorino C. An International Inter-Consortium Validation of Knowledge-Based Plan Prediction Modeling for Whole Breast Radiotherapy Treatment. Cancers (Basel). 2025 Nov 5;17(21):3576. doi: 10.3390/cancers17213576.

MeSH Terms

Conditions

Breast NeoplasmsProstatic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • Claudio Fiorino, Msc

    IRCCS Ospedale San Raffaele

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 12, 2024

First Posted

March 19, 2024

Study Start

October 28, 2022

Primary Completion

October 28, 2022

Study Completion

October 28, 2025

Last Updated

March 20, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations